PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
PRODUCTS SOLD BY ASCEND PEPTIDES ARE INTENDED FOR RESEARCH USE ONLY.
Laboratory research material
⚠ Important – Acetic Acid Water (AA Water) Handling Notice
Previous product handling guidance identified Acetic Acid Water (AA Water) for the CJC-1295 WITHOUT DAC vial in this bundle. This notice applies ONLY to the CJC-1295 WITHOUT DAC vial — not the other peptide(s) in the bundle.
The manufacturer-specific solvent requirement is awaiting verification. Do not assume that bacteriostatic water is interchangeable. Follow a validated laboratory protocol.
For laboratory research only. Not for human use.
GH-IGF-1 Axis Research Complex –An advanced research bundle designed to explore GH-IGF-1 axis signalling pathways and peptide interactions.This combination includes an IGF analogue alongside growth hormone-related peptides; the bundle does not imply a combined effect.Includes:• IGF-1 LR3 1 mg• CJC-1295 (WITHOUT DAC) 10mg• Ipamorelin 10mgBuilt for research into GH-IGF-1 axis signaling mechanisms.For research purposes only. Not for human consumption.
No laboratory certificate is published for this product. A report covers only the product and strength it names. Published reports are listed on the Certificates of Analysis page.
GH-IGF-1 Axis Research Complex — IGF-1 LR3 1mg + CJC-1295 (Without DAC) 10mg + Ipamorelin 10mg Research Bundle UK
The GH-IGF-1 Axis Research Complex covers three intervention points across the GH-IGF-1 axis in a single bundle: CJC-1295 Without DAC (upstream GHRHR activation), Ipamorelin (parallel GHSR-1a activation), and IGF-1 LR3 (downstream IGF-1 receptor signalling). CJC-1295 and Ipamorelin stimulate GH secretion through mechanistically distinct pituitary receptors, while IGF-1 LR3 — a modified 83-amino acid IGF-1 analogue with reduced binding to IGF-binding proteins — acts directly at the IGF-1 receptor rather than through GH release. In whole-animal designs, endogenous IGF-1 is still present and CJC-1295 and Ipamorelin raise GH and, through it, IGF-1, so the three components are not independent and combined designs need appropriate controls.
This three-compound design is suited to research programmes investigating the complete GH-IGF-1 signalling cascade, from upstream secretagogue activity through to downstream receptor engagement, within a single experimental system.
Janoshik has independently tested samples of IGF-1 LR3 1mg, CJC-1295 Without DAC 10mg and Ipamorelin 10mg. Their published Certificates of Analysis report measured content and purity for the tested batches and can be reviewed before purchase. LC-MS identity data is not separately reported on the published certificates, and a certificate applies to the batch it names.
Ascend Peptides UK does not publish preparation or in-use instructions for any component of this bundle; these are decisions for your own validated laboratory protocol. Components may have different handling requirements; refer to the relevant product-specific storage and handling information.
For complete mechanism detail on each compound, see the IGF-1 LR3, CJC-1295, and Ipamorelin research guides on the Ascend Peptides UK blog, or the GH axis research peptides category page.
All three compounds are listed on the WADA Prohibited List, prohibited at all times.
For in-vitro laboratory research only. Not for human consumption, therapeutic, diagnostic, or clinical use. Not classified as a medicinal product by the MHRA.
Other laboratory research materials supplied by Ascend Peptides UK.
UK same working-day dispatch – Secure payment options –
Laboratory research only
© 2026 by Ascend Peptides Uk.
All products sold by Ascend Peptides UK are intended strictly for laboratory research purposes only. Not intended for human consumption or therapeutic use of any kind.
